09:21:28 EDT Mon 14 Jul 2025
Enter Symbol
or Name
USA
CA



MedX Health Corp
Symbol MDX
Shares Issued 41,345,511
Close 2013-04-04 C$ 0.05
Market Cap C$ 2,067,276
Recent Sedar Documents

MedX Health appoints Canitano as president, COO

2013-04-05 10:22 ET - News Release

Mr. Louie Canitano reports

MEDX NAMES LOUIE CANITANO AS PRESIDENT AND CHIEF OPERATING OFFICER

MedX Health Corp.'s board of directors has appointed Louie Canitano as president and chief operating officer effective immediately.

In his new role as president and chief operating officer Mr. Canitano will oversee all operational, financial and corporate aspects of the company and will focus on executing the strategic plan approved by the board. MedX's patented medical device technology for the early detection of skin cancer is the company's leading product and as such will be the focal point of its development and marketing strategy. This product has the potential to create a new and substantial revenue stream for MedX.

Mr. Canitano joined MedX in February, 2010, as executive vice-president, operations. He has a deep understanding of operating emerging growth medical device technology companies, and brings to MedX over 18 years of operational medical device experience focusing on engineering, proprietary intellectual property, management and corporate assignments. Mr. Canitano is uniquely suited to anticipate trends and quickly respond to regulatory changes and financing challenges, and has experience in all sectors including sales and marketing, regulatory, IP, design and development, and also holds a patent surrounding laser therapy. Mr. Canitano began his career with managing G code and Schedule 5-based OHIP physiotherapy and multidisciplinary clinics, introducing and utilizing laser therapy as a palliative modality. He has a bachelor of sciences in natural health sciences.

Mr. Canitano states: "Skin cancer represents the fastest growing form of cancer in the world and affects all age groups. Detecting skin cancer early is the key to long-term survival rates and therefore MedX will seek unique strategic relationships that give ease of access to our technology. This includes partnering with thought leaders, advocacy partners, and strategic channel partners to ensure our technology has global reach."

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.